APA

Damm F., Thol F., Kosmider O., Kade S., Löffeld P., Dreyfus F., Stamatoullas-Bastard A., Tanguy-Schmidt A., Beyne-Rauzy O., de Botton S., Guerci-Bresler A., Göhring G., Schlegelberger B., Ganser A., Bernard O. A., Fontenay M. & Heuser M. (20120705). SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. : Leukemia.

Chicago

Damm F, Thol F, Kosmider O, Kade S, Löffeld P, Dreyfus F, Stamatoullas-Bastard A, Tanguy-Schmidt A, Beyne-Rauzy O, de Botton S, Guerci-Bresler A, Göhring G, Schlegelberger B, Ganser A, Bernard O A, Fontenay M and Heuser M. 20120705. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. : Leukemia.

Harvard

Damm F., Thol F., Kosmider O., Kade S., Löffeld P., Dreyfus F., Stamatoullas-Bastard A., Tanguy-Schmidt A., Beyne-Rauzy O., de Botton S., Guerci-Bresler A., Göhring G., Schlegelberger B., Ganser A., Bernard O. A., Fontenay M. and Heuser M. (20120705). SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. : Leukemia.

MLA

Damm F, Thol F, Kosmider O, Kade S, Löffeld P, Dreyfus F, Stamatoullas-Bastard A, Tanguy-Schmidt A, Beyne-Rauzy O, de Botton S, Guerci-Bresler A, Göhring G, Schlegelberger B, Ganser A, Bernard O A, Fontenay M and Heuser M. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. : Leukemia. 20120705.